Hospital-Wide Healthcare-associated Bloodstream Infections: surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities that participated in 2015-2016 as well as in at least one year between 2011-2012 and 2014-2015. No non-catheter-related primary bloodstream infection (non-CRBSI) with a mucosal barrier injury (MBI) is observed in 2015-2016. The 2015-2016 incidence rate shows a decrease compared to the 2011-2015 incidence rate. A minimum of 11 periods of data are to be provided for facilities’ data to be included in this surveillance report. Data were extracted on May 31st, 2016.

Updated : March 3, 2017
Version française

Table 1—Participation of Healthcare Facilities in the Hospital-Wide Surveillance of BSIs, Québec, 2011–2012 to 2015–2016

 

2011-2012

2012-2013

2013-2014

2014-2015

2015-2016

Participating facilities (N)

59

64

73

89

87

Admissions (N)

409,435

482,354

520,772

633,252

649,388

Patient-days (N)

3,226,042

3,791,482

3,998,173

4,740,371

4,770,053

BSIs (cat. 1a, 1b and 1c, N)

2,250

2,683

2,457

3,021

3,173

Infected patients (N)

2,147

2,567

2,295

2,819

2,948

In 2015–2016, the total incidence rate is 5.45 BSIs per 10,000 patient-days. The incidence rates are much higher in intensive care units (ICUs) than in other units (Table 2), and they are higher in teaching compared to non-teaching facilities (Figure 1). Catheter-related bloodstream infections (CRBSIs) are the most common BSIs in ICUs (Table 2 and Figure 2). In other units, the incidence rates vary depending on the type of healthcare facility: non-CRBSI are the most common primary BSIs in teaching facilities, while BSIs secondary to urinary tract infections are the most common in non-teaching facilities (Table 2 and Figure 3).

Figure 1—BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Québec, 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

¥    Significant difference (p ˂ 0,05) between teaching and non-teaching facilities.

Figure 2—BSI Incidence Rate in ICUs, For Each Type of Infection, by Type of Healthcare Facility and Type of ICU, Québec, 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 3—BSI Incidence Rate in Non-ICU Units, for Each Type of Infection, by Type of Healthcare Facility, Québec, 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

¥    Significant difference (p ˂ 0,05) between teaching and non-teaching facilities.

Table 2—BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

 

 

Primary BSIs

Secondary BSIs

Total

CRBSI-MBICRBSINon-CRBSIHDUrinary tractAbdominalPulmonarySSIOthers**
Total hospitalized

0.20 [0.16 ; 0.24]

1.05 [0.96 ; 1.14]

1.12 [1.03 ; 1.22]

0.03 [0.02 ; 0.05]

1.10 [1.01 ; 1.20]

0.58 [0.51 ; 0.65]

0.55 [0.49 ; 0.62]

0.52 [0.46 ; 0.59]

0.31 [0.26 ; 0.36]

5.45 [5.24 ; 5.66]

Teaching

0.38 [0.31 ; 0.46]

1.63 [1.47 ; 1.80]

1.45 [1.30 ; 1.61]

0.05 [0.03 ; 0.08]

1.18 [1.05 ; 1.32]

0.90 [0.78 ; 1.02]

0.61 [0.52 ; 0.71]

0.73 [0.63 ; 0.84]

0.39 [0.31 ; 0.47]

7.32 [6.98 ; 7.67]

Non-teaching

0.01 [0 ; 0.03]

0.46 [0.38 ; 0.55]

0.78 [0.67 ; 0.90]

0.02 [0.01 ; 0.04]

1.02 [0.90 ; 1.15]

0.26 [0.20 ; 0.33]

0.49 [0.40 ; 0.58]

0.31 [0.24 ; 0.38]

0.22 [0.16 ; 0.28]

3.56 [3.32 ; 3.80]

ICUs

0.06 [0 ; 0.18]

5.64 [4.84 ; 6.51]

2.64 [2.10 ; 3.24]

0.06 [0 ; 0.18]

1.09 [0.75 ; 1.49]

1.67 [1.25 ; 2.16]

2.38 [1.87 ; 2.95]

1.13 [0.79 ; 1.53]

0.39 [0.20 ; 0.64]

15.07 [13.74 ; 16.47]

Adult teaching

0.08 [0 ; 0.31]

4.89 [3.77 ; 6.16]

2.60 [1.80 ; 3.55]

0.15 [0.01 ; 0.43]

1.68 [1.05 ; 2.46]

1.45 [0.87 ; 2.18]

3.59 [2.64 ; 4.69]

2.14 [1.42 ; 3.01]

0.38 [0.12 ; 0.79]

16.95 [14.79 ; 19.25]

Adult non-teaching

0

2.48 [1.55 ; 3.62]

2.93 [1.91 ; 4.16]

0

1.01 [0.46 ; 1.78]

1.35 [0.69 ; 2.22]

2.70 [1.73 ; 3.89]

0.68 [0.25 ; 1.33]

0.45 [0.12 ; 1.00]

11.60 [9.47 ; 13.95]

Pediatric

0

12.88 [7.34 ; 19.96]

3.22 [0.84 ; 7.15]

0

0

0

0

0

0

16.91 [10.45 ; 24.91]

Neonatal

0.13 [0 ; 0.51]

9.32 [7.30 ; 11.58]

2.30 [1.36 ; 3.48]

0

0.38 [0.07 ; 0.93]

2.55 [1.55 ; 3.79]

0.38 [0.07 ; 0.93]

0.13 [0 ; 0.51]

0.38 [0.07 ; 0.93]

15.58 [12.94 ; 18.47]

Non-ICU units

0.21 [0.17 ; 0.25]

0.73 [0.65 ; 0.81]

1.01 [0.92 ; 1.11]

0.03 [0.02 ; 0.05]

1.10 [1.00 ; 1.20]

0.50 [0.44 ; 0.57]

0.42 [0.36 ; 0.48]

0.48 [0.42 ; 0.55]

0.30 [0.25 ; 0.35]

4.78 [4.58 ; 4.98]

Teaching

0.41 [0.33 ; 0.50]

1.10 [0.97 ; 1.24]

1.34 [1.19 ; 1.50]

0.05 [0.02 ; 0.08]

1.19 [1.05 ; 1.34]

0.80 [0.69 ; 0.92]

0.45 [0.37 ; 0.54]

0.67 [0.57 ; 0.78]

0.40 [0.32 ; 0.49]

6.42 [6.09 ; 6.76]

Non-teaching

0.01 [0 ; 0.03]

0.37 [0.30 ; 0.45]

0.69 [0.59 ; 0.80]

0.02 [0.01 ; 0.04]

1.01 [0.88 ; 1.14]

0.21 [0.15 ; 0.27]

0.40 [0.32 ; 0.49]

0.29 [0.22 ; 0.36]

0.21 [0.15 ; 0.27]

3.22 [2.99 ; 3.45]

Note: When the incidence rate is 0, the confidence interval [CI] is not calculated.
** The “Others” column also includes secondary BSIs arising from a skin, soft tissue, bone or joint infection.

The BSI incidence rate in 2015–2016 decreased compared with the 2011–2015 pooled rate (Table 3). This decrease was driven by certain types of bloodstream infections (Figure 4). The most important decreases in incidence rates are observed in BSIs secondary to urinary tract infections and to surgical site infections (SSIs).

Figure 4 - BSI Incidence Rate, by Type of Infection, in Facilities that Previously participated in Surveillance (N = 86) 1, Québec, 2011–2015 and 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])*, Québec, 2011–2015 and 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

¥ Significant difference (p ˂ 0,05) between 2011-2015 and 2015-2016.

Table 3—BSI Incidence Rate, by Type of Healthcare Facility, in Facilities that Previously participated in Surveillance (N = 86)*, Québec, 2011–2015 and 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

Facilities

Number of Facilities

Incidence Rate

2011-2015

2015-2016

Teaching

25

7.49 [7.30 ; 7.68]

7.26 [6.91 ; 7.62]

Non-teaching

61

3.64 [3.51 ; 3.78]

3.56 [3.32 ; 3.80]

Total

86

5.57 [5.46 ; 5.69]

5.35 [5.14 ; 5.56]

* Analyses performed on data from facilities that participated in 2015-2016 as well as in at least one year between 2011-2012 and 2014-2015.

Although the incidence rates are higher in ICUs, most BSIs occurred in non-ICU units (67.2%, Table 4 and Figure 5), where 93% of patient-days are counted (n = 4,459,543 patient-days). CRBSIs are the most commonly encountered BSIs in ICUs, whereas BSIs secondary to urinary tract infections are the most common in non-ICU units.

Figure 5 – Breakdown of Cases Based on Type of Unit and Type of ICU, Québec, 2015–2016 (%)

Figure 6 - Breakdown of Cases Based on Type of BSI, for Teaching and Non-Teaching Healthcare Facilities, Québec, 2015–2016 (%)

Table 4 - Number of Cases for Each Type of BSI, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2015–2016 (N)

 

 

Primary BSIs

Secondary BSIs

Total

CRBSI-MBICRBSINon-CRBSIHDUrinary tractAbdominalPulmonarySSIOthers*
Total hospitalized

94

500

532

16

524

276

263

248

146

2 599

Teaching

92

391

348

12

282

215

146

175

94

1 755

Non-teaching

2

109

184

4

242

61

117

73

52

844

ICU

2

175

82

2

34

52

74

35

12

468

Adult, teaching 

1

64

34

2

22

19

47

28

5

222

Adult, non-teaching 

0

22

26

0

9

12

24

6

4

103

Pediatric

0

16

4

0

0

1

0

0

0

21

Neonatal

1

73

18

0

3

20

3

1

3

122

Non-ICU hospitalization

92

325

450

14

490

224

189

213

134

2 131

Teaching

90

240

292

10

259

175

98

146

87

1 397

Non-teaching

2

85

158

4

231

49

91

67

47

734

* The "Others" column also includes BSIs secondary to skin, soft tissue, bone or joint infection.

Overall, 17.8% of BSI cases resulted in death within 30 days of bacteremia onset (Table 5). Case fatality is highest in patients with a BSI secondary to a pulmonary infection (Table 5).

Figure 7 - 30-Day Case Fatality for Each Type of Infection, Québec, 2015–2016 (%)

Table 5 - 10-Day and 30-Day Case Fatality for Each Type of Infection, 2015–2016 (N, %)

 

 

BSIs

10-day case fatality

30-day case fatality

(N)

N

%

N

%

Primary BSIs     
   CRBSI-MBI

101

2

2.0

5

5.0

   CRBSI

603

33

5.5

60

10.0

   Non-CRBSI

728

119

16.3

166

22.8

   HD

139

9

6.5

16

11.5

      
Secondary BSIs     
   Urinary tract

597

45

7.5

78

13.1

   Abdominal

291

59

20.3

80

27.5

   Pulmonary 

269

60

22.3

88

32.7

   SSI

275

19

6.9

37

13.5

   Skin and soft tissues

93

13

14.0

21

22.6

   Bone and joints

12

1

8.3

1

8.3

   Others

65

9

13.8

12

18.5

Total

3,173

369

11.6

564

17.8

Escherichia coli is the most frequently isolated microorganism in reported cases (22% of BSIs, Table 6). Candida sp. and Pseudomonas sp. are the microorganisms associated with the higher case fatality. Staphylococcus aureus is the most frequently isolated microorganism in CRBSI, hemodialysis-related BSIs and in BSIs secondary to a pulmonary infection or a SSI. In patients with a non-CRBSI, CRBSI-MBI or a BSI secondary to a urinary tract or abdominal infection, enterobacteria are the most common microorganisms.

Figure 8 – Breakdown of Categories of Isolated Microorganisms in All Cases (N = 3,501) and Cases of Fatality Within 30 Days (N = 645), Québec, 2015–2016 (%)

Figure 9 – Breakdown of Categories of Isolated Microorganisms, for Each Type of BSI, Québec, 2015–2016 (%)

 * This column includes the sum of the other columns as well as secondary BSIs arising from a skin, soft tissue, bone or joint infection, or another source.

Tableau 6 – Breakdown of Microorganisms associated with BSIs, for each Type of BSI, for all BSIs and for those associated with a Fatality Within 30 Days, Québec, 2015–2016 (N, %)

Microorganism

Primary BSIs

Secondary BSIs

Total

30-day Case Fatality

CRBSI – MBICRBSINon-CRBSIHDUrinary tractAbdominalPulmonaryISOOthers*

n

%

Enterobacteria

86

108

369

13

442

166

80

83

31

1 378

226

16.4

   E. coli

39

22

219

5

298

95

29

42

17

766

122

15.9

   Klebsiella sp.

33

35

89

2

83

37

25

17

8

329

54

16.4

   Other enterobacteriaceae

14

51

61

6

61

34

26

24

6

283

50

17.7

S. aureus

0

199

100

79

33

9

99

87

70

676

134

19.8

CoNS

0

168

41

29

13

2

2

9

10

274

33

12.0

Enterococcus sp.

6

45

93

6

54

45

8

30

20

307

73

23.8

Candida sp.

2

53

26

2

20

22

12

13

3

153

50

32.7

Anaerobic

6

0

15

0

1

29

3

29

5

88

15

17.0

Pseudomonas sp.

0

18

42

4

41

20

22

8

8

163

35

21.5

Others

11

84

111

18

30

51

72

49

36

462

79

17.1

Total

111

675

797

151

634

344

298

308

183

3 501

645

18.4

* This column includes the sum of the other columns as well as secondary BSIs arising from a skin, soft tissue, bone or joint infection, or another source.

Methicillin-resistant S. aureus (MRSA) accounted for 12.3% (83 / 676) of S. aureus BSIs in all healthcare units (Table 7 and Figure 10).

Table 7 – Proportion of Strains Tested and Proportion of Resistance to Antibiotics for Selected Isolated Microorganisms, Québec, 2015–2016 (N, %)

MicroorganismAntibiotic

Isolated

Tested

Resistant

N

N

%

N

%

Staphylococcus aureusOxacilline

676

676

100.0

83

12.3

EnterococcusVancomycine

261

260

99.6

16

6.2

   Enterococcus faecalisVancomycine

157

156

99.4

0

0.0

   Enterococcus faeciumVancomycine

104

104

100.0

16

15.4

Klebsiella sp.CSE 4

315

295

93.7

18

6.1

Imipenem or meropenem

315

207

65.7

0

0.0

Multiresistant 1

315

310

98.4

8

2.6

Escherichia coliCSE 4

728

607

83.4

78

12.9

Fluoroquinolones 3

728

666

91.5

182

27.3

Imipenem or méropenem

728

457

62.8

0

0.0

Multiresistant 1

728

673

92.4

27

4.0

Enterobacter sp.CSE 4

112

107

95.5

28

26.2

Imipenem or meropenem

112

87

77.7

2

2.3

Multiresistant 1

112

107

95.5

0

0.0

Carbapénèmes

112

98

87.5

4

4.1

Pseudomonas sp.Amikacine. gentamicine ou tobramycine

157

129

82.2

8

6.2

CSE 2

157

147

93.6

9

6.1

Fluoroquinolones 2

157

152

96.8

11

7.2

Imipénem ou méropénem

157

146

93.0

27

18.5

Pipéracilline-tazobactam

157

113

72.0

5

4.4

Multirésistant 2

157

155

98.7

9

5.8

Acinetobacter sp.Imipénem ou méropénem

12

12

100.0

0

0.0

Multirésistant 3

12

5

41.7

0

0.0

CSE 4 : cefepime, cefotaxime, ceftazidime or ceftriaxone;
CSE 2 : cefepime or ceftazidime; 
Fluoroquinolones 2 : ciprofloxacin ou levofloxacin;
Fluoroquinolones 3 : ciprofloxacin, levofloxacin or moxifloxacine;
Multiresistant 1 : intermediate or resistant to an agent in three of the following five categories: cephalosporins 4, fluoroquinolones 3, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam;
Multiresistant 2 : intermediate or resistant to an agent in three of the following five categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam;
Multiresistant 3 : intermediate or resistant to an agent in three of the following six categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam, ampicillin/sulbactam.

Figure 10 – Antibiotic Resistance in Gram-Positive Bacteria, Gram-Negative Bacteria and Pseudomonas sp., Québec, 2011–2015 to 2015–2016 (%)

Table 8 presents 2015-2016 rates of CRBSI and of BSIs secondary to urinary tract and pulmonary infections, per healthcare facility.

Figure 11 – BSI Incidence Rate per Facility (2015–2016) and Percentile Ranking (2011–2012 to 2014–2015) for Teaching Healthcare Facilities, Québec, 2015–2016

Figure 12 – BSI Incidence Rate per Facility (2015–2016) and Percentile Ranking (2011–2012 to 2014–2015) for Non-Teaching Healthcare Facilities, Québec, 2015–2016

Note: facilities 49, 59, 70, 77, 82, 83, 84, 85, 95, 96 and 109 reported no admitted case of BSI in 2015-2016.

Table 8 – Incidence Rates of CRBSI and of BSIs Secondary to Urinary Tract and Pulmonary Infections per Facility, for Teaching Healthcare Facilities, Québec, 2015–2016 (Incidence Rate per 10,000 Patient-Days [95% CI])

Facility

CRBSI

Urinary Tract

Pulmonary

Case (n)

Incidence rates

Case (n)

Incidence rates

Case (n)

Incidence rates

1HÔPITAL CHARLES LEMOYNE

9

0.70 [0.32 ; 1.23]

4

0.31 [0.08 ; 0.69]

3

0.23 [0.04 ; 0.57]

2HÔPITAL DE L'ENFANT-JÉSUS

16

1.25 [0.71 ; 1.94]

17

1.32 [0.77 ; 2.02]

11

0.86 [0.43 ; 1.44]

3GLEN - ROYAL VICTORIA

38

3.46 [2.45 ; 4.65]

16

1.46 [0.83 ; 2.26]

19

1.73 [1.04 ; 2.60]

4HÔPITAL NOTRE-DAME DU CHUM

37

3.61 [2.54 ; 4.87]

17

1.66 [0.97 ; 2.54]

11

1.07 [0.53 ; 1.80]

5HÔPITAL GÉNÉRAL JUIF

32

1.90 [1.30 ; 2.62]

34

2.02 [1.40 ; 2.76]

15

0.89 [0.50 ; 1.40]

6GLEN - ENFANTS

63

14.95 [11.49 ; 18.87]

1

0.24 [0 ; 0.94]

0

0

7PAVILLON L'HÔTEL-DIEU DE QUÉBEC

8

0.93 [0.40 ; 1.69]

21

2.45 [1.51 ; 3.61]

7

0.82 [0.33 ; 1.54]

8PAVILLON MAISONNEUVE/PAVILLON MARCEL-LAMOUREUX

33

1.76 [1.21 ; 2.41]

32

1.71 [1.17 ; 2.35]

10

0.53 [0.25 ; 0.91]

9HÔPITAL DU HAUT-RICHELIEU

5

0.61 [0.19 ; 1.26]

13

1.58 [0.84 ; 2.56]

4

0.49 [0.13 ; 1.09]

10HÔPITAL PIERRE-BOUCHER

5

0.46 [0.15 ; 0.95]

11

1.00 [0.50 ; 1.68]

7

0.64 [0.25 ; 1.20]

11HÔPITAL PIERRE-LE GARDEUR

5

0.45 [0.14 ; 0.93]

19

1.69 [1.01 ; 2.54]

5

0.45 [0.14 ; 0.93]

12CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE

36

4.02 [2.81 ; 5.44]

3

0.33 [0.06 ; 0.81]

1

0.11 [0 ; 0.43]

13INSTITUT DE CARDIOLOGIE DE MONTRÉAL

2

0.47 [0.04 ; 1.35]

1

0.24 [0 ; 0.93]

4

0.95 [0.25 ; 2.11]

14CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE

7

0.72 [0.29 ; 1.35]

13

1.34 [0.71 ; 2.17]

8

0.82 [0.35 ; 1.49]

15HÔPITAL FLEURIMONT

24

2.30 [1.47 ; 3.31]

14

1.34 [0.73 ; 2.13]

3

0.29 [0.06 ; 0.71]

16HÔPITAL RÉGIONAL DE RIMOUSKI

2

0.36 [0.03 ; 1.03]

7

1.27 [0.50 ; 2.38]

4

0.73 [0.19 ; 1.62]

18HÔTEL-DIEU DE LÉVIS

4

0.54 [0.14 ; 1.20]

17

2.28 [1.33 ; 3.49]

6

0.80 [0.29 ; 1.57]

19HÔPITAL CITÉ DE LA SANTÉ

24

1.41 [0.90 ; 2.03]

20

1.17 [0.71 ; 1.74]

4

0.23 [0.06 ; 0.51]

20HÔPITAL DE CHICOUTIMI

6

0.78 [0.28 ; 1.53]

6

0.78 [0.28 ; 1.53]

0

0

21HÔPITAL SAINT-LUC DU CHUM

17

1.68 [0.98 ; 2.57]

12

1.19 [0.61 ; 1.96]

4

0.40 [0.11 ; 0.88]

22HÔTEL-DIEU DU CHUM

12

1.76 [0.91 ; 2.90]

11

1.61 [0.80 ; 2.70]

8

1.17 [0.50 ; 2.12]

23HÔTEL-DIEU D'ARTHABASKA

0

0

0

0

6

1.16 [0.42 ; 2.28]

24HÔPITAL DU SAINT-SACREMENT

4

0.74 [0.19 ; 1.64]

4

0.74 [0.19 ; 1.64]

2

0.37 [0.04 ; 1.06]

25HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL

47

3.26 [2.39 ; 4.26]

28

1.94 [1.29 ; 2.73]

9

0.63 [0.29 ; 1.11]

26HÔPITAL DE VERDUN

10

1.28 [0.61 ; 2.20]

8

1.03 [0.44 ; 1.87]

6

0.77 [0.28 ; 1.51]

27PAVILLON CENTRE HOSPITALIER DE L'UNIVERSITÉ LAVAL

14

1.18 [0.64 ; 1.88]

2

0.17 [0.02 ; 0.49]

3

0.25 [0.05 ; 0.62]

28PAVILLON SAINT-FRANCOIS D'ASSISE

9

1.02 [0.46 ; 1.80]

18

2.04 [1.21 ; 3.09]

6

0.68 [0.24 ; 1.33]

29HÔPITAL GÉNÉRAL DE MONTRÉAL

17

2.20 [1.28 ; 3.37]

10

1.29 [0.61 ; 2.22]

12

1.55 [0.80 ; 2.55]

30HOTEL-DIEU DE SHERBROOKE

8

1.22 [0.52 ; 2.21]

6

0.92 [0.33 ; 1.80]

2

0.31 [0.03 ; 0.88]

31PAVILLON SAINTE-MARIE

2

0.16 [0.02 ; 0.46]

8

0.64 [0.27 ; 1.16]

7

0.56 [0.22 ; 1.05]

32CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE

1

0.37 [0 ; 1.45]

2

0.74 [0.07 ; 2.12]

1

0.37 [0 ; 1.45]

33INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

15

1.57 [0.88 ; 2.47]

4

0.42 [0.11 ; 0.93]

0

0

34HÔPITAL SANTA CABRINI

1

0.09 [0 ; 0.36]

20

1.90 [1.16 ; 2.82]

7

0.66 [0.26 ; 1.24]

35HÔPITAL HONORÉ-MERCIER

1

0.15 [0 ; 0.59]

7

1.04 [0.41 ; 1.95]

3

0.45 [0.09 ; 1.10]

36HÔPITAL GÉNÉRAL DU LAKESHORE

2

0.28 [0.03 ; 0.80]

14

1.93 [1.05 ; 3.07]

8

1.10 [0.47 ; 2.00]

37HÔTEL-DIEU DE SOREL

4

0.89 [0.23 ; 1.98]

6

1.33 [0.48 ; 2.61]

3

0.67 [0.13 ; 1.64]

38HÔPITAL JEAN-TALON

3

0.60 [0.11 ; 1.47]

10

2.00 [0.95 ; 3.43]

9

1.80 [0.82 ; 3.17]

39HOPITAL DE GATINEAU

-

-

-

-

-

-

40HÔPITAL DE HULL

4

0.60 [0.16 ; 1.33]

14

2.11 [1.15 ; 3.36]

6

0.90 [0.32 ; 1.77]

41HÔPITAL DU CENTRE-DE-LA-MAURICIE

2

0.43 [0.04 ; 1.23]

9

1.92 [0.87 ; 3.38]

0

0

42CENTRE HOSPITALIER ANNA-LABERGE

1

0.14 [0 ; 0.54]

10

1.35 [0.64 ; 2.32]

5

0.68 [0.22 ; 1.4]

44HÔPITAL SAINTE-CROIX

1

0.18 [0 ; 0.71]

8

1.45 [0.62 ; 2.63]

1

0.18 [0 ; 0.71]

45HÔPITAL DE SAINT-EUSTACHE

6

0.67 [0.24 ; 1.31]

4

0.45 [0.12 ; 1.00]

0

0

46HÔPITAL DE GRANBY

3

0.63 [0.12 ; 1.54]

10

2.09 [1.00 ; 3.59]

1

0.21 [0 ; 0.82]

47HÔPITAL DE ROUYN-NORANDA

1

0.40 [0 ; 1.56]

4

1.58 [0.41 ; 3.51]

0

0

48CENTRE HOSPITALIER DE ST. MARY

7

0.88 [0.35 ; 1.65]

11

1.39 [0.69 ; 2.33]

1

0.13 [0 ; 0.50]

49CENTRE DE SANTÉ ET DE SERVICES SOCIAUX MEMPHRÉMAGOG

0

0

0

0

0

0

51HÔPITAL DE MANIWAKI

0

0

2

1.40 [0.13 ; 4.01]

0

0

52HÔPITAL D'AMOS

0

0

1

0.41 [0 ; 1.61]

0

0

53HÔPITAL DE CHANDLER

0

0

0

0

1

0.79 [0 ; 3.09]

56CENTRE DE SANTÉ ET DE SERVICES SOCIAUX D'ARGENTEUIL

3

2.09 [0.39 ; 5.12]

1

0.70 [0 ; 2.74]

1

0.70 [0 ; 2.74]

58HÔPITAL DU SUROÎT

6

0.99 [0.36 ; 1.94]

9

1.49 [0.68 ; 2.62]

2

0.33 [0.03 ; 0.95]

59HÔPITAL DE BAIE-SAINT-PAUL

0

0

0

0

0

0

61HÔPITAL NOTRE-DAME-DE-FATIMA

0

0

0

0

0

0

63HÔPITAL DE SAINT-GEORGES

0

0

2

0.51 [0.05 ; 1.46]

0

0

64HÔPITAL LE ROYER

0

0

3

1.17 [0.22 ; 2.86]

2

0.78 [0.07 ; 2.23]

65HÔPITAL ET CLSC DE VAL-D'OR

3

1.23 [0.23 ; 3.02]

3

1.23 [0.23 ; 3.02]

3

1.23 [0.23 ; 3.02]

67HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE

0

0

5

1.36 [0.43 ; 2.82]

2

0.55 [0.05 ; 1.57]

70CENTRE DE SOINS DE COURTE DURÉE LA SARRE

0

0

0

0

0

0

71HÔPITAL DE MATANE

0

0

2

1.50 [0.14 ; 4.30]

0

0

72HÔPITAL ET CENTRE D'HÉBERGEMENT DE SEPT-ÎLES

0

0

0

0

0

0

74HÔPITAL DE DOLBEAU-MISTASSINI

1

0.60 [0 ; 2.34]

1

0.60 [0 ; 2.34]

0

0

75CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU GRANIT

0

0

1

1.14 [0 ; 4.47]

0

0

76HÔPITAL DE LACHINE

1

0.59 [0 ; 2.32]

2

1.19 [0.11 ; 3.41]

2

1.19 [0.11 ; 3.41]

77HÔPITAL D'AMQUI

0

0

0

0

0

0

80HÔPITAL FLEURY

8

1.81 [0.77 ; 3.28]

10

2.27 [1.08 ; 3.89]

5

1.13 [0.36 ; 2.34]

81HÔPITAL DE MONT-LAURIER

1

0.62 [0 ; 2.43]

1

0.62 [0 ; 2.43]

0

0

82PAVILLON SAINTE-FAMILLE

0

0

0

0

0

0

83HÔPITAL DE LASALLE

0

0

0

0

0

0

84HÔPITAL DE NOTRE-DAME-DU-LAC

1

1.32 [0 ; 5.17]

0

0

0

0

85CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU HAUT-SAINT-MAURICE

0

0

0

0

0

0

86HÔPITAL DE LA MALBAIE

0

0

4

4.03 [1.05 ; 8.95]

1

1.01 [0 ; 3.96]

88HÔPITAL. CLSC ET CENTRE D'HÉBERGEMENT DE ROBERVAL

0

0

7

2.46 [0.98 ; 4.62]

0

0

89HÔPITAL DE MONTMAGNY

2

1.15 [0.11 ; 3.30]

2

1.15 [0.11 ; 3.3]

0

0

91HÔPITAL HÔTEL-DIEU DE GASPÉ

0

0

1

0.92 [0 ; 3.60]

0

0

95HÔPITAL DU PONTIAC

0

0

0

0

0

0

96CENTRE DE SANTÉ DE CHIBOUGAMAU

0

0

0

0

0

0

97HÔPITAL DE MARIA

1

0.55 [0 ; 2.16]

2

1.10 [0.10 ; 3.15]

1

0.55 [0 ; 2.16]

99HÔPITAL BROME-MISSISQUOI-PERKINS

2

0.72 [0.07 ; 2.06]

2

0.72 [0.07 ; 2.06]

1

0.36 [0 ; 1.41]

100HÔPITAL DE LA BAIE

0

0

1

0.76 [0 ; 2.97]

0

0

101HÔPITAL RÉGIONAL DE SAINT-JÉRÔME

17

1.55 [0.90 ; 2.37]

15

1.36 [0.76 ; 2.14]

10

0.91 [0.43 ; 1.56]

103HÔPITAL LAURENTIEN

3

1.00 [0.19 ; 2.45]

1

0.33 [0 ; 1.30]

0

0

107HÔPITAL DE L'ARCHIPEL

1

1.31 [0 ; 5.13]

1

1.31 [0 ; 5.13]

0

0

109HÔPITAL DE SAINTE-ANNE-DES-MONTS

1

1.62 [0 ; 6.35]

0

0

0

0

111HÔPITAL DE PAPINEAU

0

0

1

0.54 [0 ; 2.11]

0

0

112HÔPITAL D'ALMA

1

0.35 [0 ; 1.38]

2

0.71 [0.07 ; 2.03]

1

0.35 [0 ; 1.38]

113HÔPITAL DE THETFORD MINES

0

0

1

0.43 [0 ; 1.69]

0

0

118HÔPITAL NEUROLOGIQUE DE MONTRÉAL

3

1.35 [0.25 ; 3.31]

8

3.61 [1.54 ; 6.55]

5

2.26 [0.71 ; 4.67]

130HOPITAL BARRIE MEMORIAL

-

-

-

-

-

-

95% CI: 95% confidence interval
BSI: bloodstream infection
CoNS: coagulase-negative Staphylococcus
CRBSI: catheter-related bloodstream infection
HD: hemodialysis
ICU: intensive care unit
MBI: mucosal barrier injury
Non-CRBSI: non-catheter-related primary bloodstream infection
SSI: surgical site infection

Comité de surveillance provinciale des infections nosocomiales (SPIN) – bactériémies panhospitalières

Editorial Committee 

Alex Carignan, Centre hospitalier universitaire de Sherbrooke

Christophe Garenc, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Élise Fortin, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Danielle Moisan, Centre hospitalier régional du Grand-Portage

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Isabelle Rocher, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Jasmin Villeneuve, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec